Valvular heart disease associated with benfluorex therapy: high prevalence in patients with unexplained restrictive valvular heart disease

By Boudes Audrey   Lavoute Cécile   Avierinos Jean-François   Le Dolley Yvan   Villacampa Chloe   Salem Adrien   Loundou Anderson Dieudonné   Michel Nicolas   Renard Sébastien   Habib Gilbert  

European Journal of Echocardiography, Vol. 12, Iss. 9, 2011-09 ,pp. : 688-695

Oxford University Press

Access to resources Recommend Favorite

Efficacy of Cabergoline in Long-Term Use: Results of Three Observational Studies in 1,500 Patients with Parkinson’s Disease

By  

European Neurology, Vol. 46, Iss. 1, 2001-12 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

Patients with ischemic heart disease: Quality of life predicts long-term mortality

By Westin L.   Nilstun T.   Carlsson R.   Erhardt L.  

Scandinavian Cardiovascular Journal, Vol. 39, Iss. 1-2, 2005-04 ,pp. : 50-54

Informa Healthcare

Access to resources Recommend Favorite

Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease

By Park Hyohun   Shima Toshihide   Yamaguchi Kanji   Mitsuyoshi Hironori   Minami Masahito   Yasui Kohichiroh   Itoh Yoshito   Yoshikawa Toshikazu   Fukui Michiaki   Hasegawa Goji   Nakamura Naoto   Ohta Mitsuhiro   Obayashi Hiroshi   Okanoue Takeshi  

Journal of Gastroenterology, Vol. 46, Iss. 1, 2011-01 ,pp. : 101-107

Springer Publishing Company

Access to resources Recommend Favorite

The Lescol^® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

By Serruys Patrick WJC   de Feyter Pim J   Benghozi Renée   Hugenholtz Paul G   Lesaffre Emmanuel  

International Journal of Cardiovascular Interventions, Vol. 4, Iss. 4, 2001-12 ,pp. : 165-172

Informa Healthcare

Access to resources Recommend Favorite